Mirati Therapeutics (MRTX) Short Interest Ratio & Short Volume Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Mirati Therapeutics Short Interest DataCurrent Short Interest4,390,000 sharesPrevious Short Interest7,400,000 sharesChange Vs. Previous Month-40.68%Dollar Volume Sold Short$257.91 millionShort Interest Ratio2.0 Days to CoverLast Record DateDecember 31, 2023Outstanding Shares70,150,000 sharesPercentage of Shares Shorted6.26%Today's Trading Volume0 sharesAverage Trading Volume2,758,857 sharesToday's Volume Vs. Average0% Short Selling Mirati Therapeutics ? Sign up to receive the latest short interest report for Mirati Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMRTX Short Interest Over TimeMRTX Days to Cover Over TimeMRTX Percentage of Float Shorted Over Time Ad DarwinTop Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report Mirati Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20234,390,000 shares $257.91 million -40.7%N/A2 $58.75 12/15/20237,400,000 shares $427.65 million +56.1%N/A3.3 $57.79 11/30/20234,740,000 shares $269.00 million -22.2%N/A2.1 $56.75 11/15/20236,090,000 shares $342.32 million +31.8%N/A2.7 $56.21 10/31/20234,620,000 shares $256.55 million -0.9%N/A2 $55.53 10/15/20234,660,000 shares $260.73 million -45.8%N/A2.1 $55.95 Get the Latest News and Ratings for MRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mirati Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/30/20238,590,000 shares $374.18 million -5.1%N/A4.4 $43.56 9/15/20239,050,000 shares $299.10 million -4.3%N/A7 $33.05 8/31/20239,460,000 shares $351.91 million -1.8%N/A8 $37.20 8/15/20239,630,000 shares $382.60 million +19.6%N/A7.7 $39.73 7/31/20238,050,000 shares $243.67 million -7.9%N/A6.9 $30.27 7/15/20238,740,000 shares $309.66 million +1.6%N/A8.5 $35.43 6/30/20238,600,000 shares $310.72 million +6.6%N/A8.3 $36.13 6/15/20238,070,000 shares $314.49 million +13.5%N/A7.7 $38.97 5/31/20237,110,000 shares $264.21 million +5.2%N/A6.8 $37.16 5/15/20236,760,000 shares $334.21 million -14.8%N/A6.9 $49.44 4/30/20237,930,000 shares $351.38 million -13.6%N/A7.9 $44.31 4/15/20239,180,000 shares $360.32 million -0.9%N/A8.6 $39.25 3/31/20239,260,000 shares $344.29 million +7.7%N/A8.3 $37.18 3/15/20238,600,000 shares $371.26 million -2.4%N/A6.8 $43.17 2/28/20238,810,000 shares $403.85 million -3.9%N/A5 $45.84 2/15/20239,170,000 shares $446.67 million -3.9%N/A4.9 $48.71 1/31/20239,540,000 shares $509.53 million -10.3%N/A4.9 $53.41 1/15/202310,630,000 shares $458.05 million +1.0%N/A5.7 $43.09 12/30/202210,530,000 shares $477.11 million +6.6%N/A5.9 $45.31 12/15/20229,880,000 shares $420.30 million +30.0%N/A5.9 $42.54 11/30/20227,600,000 shares $694.49 million -5.9%N/A5.8 $91.38 11/15/20228,080,000 shares $585.80 million +4.5%N/A8.4 $72.50 10/31/20227,730,000 shares $520.38 million -2.3%N/A10 $67.32 10/15/20227,910,000 shares $528.78 million +2.5%N/A9.4 $66.85 9/30/20227,720,000 shares $539.16 million -3.4%N/A8.4 $69.84 9/15/20227,990,000 shares $659.10 million +7.3%N/A8.1 $82.49 8/31/20227,450,000 shares $603.67 million -1.6%N/A6.7 $81.03 8/15/20227,570,000 shares $653.44 million +8.5%N/A4.8 $86.32 7/31/20226,980,000 shares $449.51 million -13.3%13.7%4.3 $64.40 7/15/20228,050,000 shares $483.16 million -2.2%24.0%5.2 $60.02 6/30/20228,230,000 shares $552.48 million +46.7%24.5%5.6 $67.13 6/15/20225,610,000 shares $302.66 million +19.1%16.7%4 $53.95 5/31/20224,710,000 shares $184.44 million -9.6%9.2%3.9 $39.16 5/15/20225,210,000 shares $296.14 million +24.1%10.2%7.1 $56.84We’re in a code red crisis and 99% of Americans are clueless (Ad)Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! 4/30/20224,200,000 shares $259.52 million +14.1%8.2%5.5 $61.79 4/15/20223,680,000 shares $301.54 million +10.8%7.2%5.2 $81.94 3/31/20223,320,000 shares $272.97 million +6.8%6.5%4.7 $82.22 3/15/20223,110,000 shares $240.47 million -7.2%6.1%4.5 $77.32 2/28/20223,350,000 shares $295.77 million +12.8%7.0%5 $88.29 2/15/20222,970,000 shares $318.95 million +2.1%6.2%4.6 $107.39 1/31/20222,910,000 shares $347.16 million +11.1%6.1%5 $119.30 1/15/20222,620,000 shares $325.69 million -4.4%5.5%4.9 $124.31 12/31/20212,740,000 shares $401.93 million -11.0%5.8%5.6 $146.69 12/15/20213,080,000 shares $434.22 million +14.1%6.5%6.1 $140.98 11/30/20212,700,000 shares $369.28 million -16.2%5.7%4.9 $136.77 11/15/20213,220,000 shares $453.34 million -16.6%6.8%5.9 $140.79 10/29/20213,860,000 shares $729.62 million -5.4%8.1%8.3 $189.02 10/15/20214,080,000 shares $727.38 million +1.5%8.6%9.3 $178.28 9/30/20214,020,000 shares $711.18 million +20.4%8.5%9.2 $176.91 9/15/20213,340,000 shares $561.39 million -7.5%7.0%6.6 $168.08 8/31/20213,610,000 shares $612.73 million -0.6%7.6%8.1 $169.73 8/13/20213,630,000 shares $508.82 million No Change7.6%8.2 $140.17 7/30/20213,630,000 shares $581.02 million +0.3%7.6%7.5 $160.06 7/15/20213,620,000 shares $574.46 million +5.2%7.4%6.2 $158.69 6/30/20213,440,000 shares $555.66 million -28.0%7.1%5.7 $161.53 6/15/20214,780,000 shares $796.35 million +4.4%9.8%9.3 $166.60 5/28/20214,580,000 shares $724.33 million +2.2%9.4%9.1 $158.15 5/14/20214,480,000 shares $693.32 million +6.7%N/A8.9 $154.76 4/30/20214,200,000 shares $690.94 million +11.7%N/A8.3 $164.51 4/15/20213,760,000 shares $607.09 million -3.3%N/A8.8 $161.46 3/31/20213,890,000 shares $645.62 million +2.9%N/A9.1 $165.97 3/15/20213,780,000 shares $718.16 million +3.3%N/A8.8 $189.99 2/26/20213,660,000 shares $715.90 million +6.4%N/A8.6 $195.60 2/12/20213,440,000 shares $726.63 million -9.7%N/A8.2 $211.23 1/29/20213,810,000 shares $776.74 million -0.8%N/A8.9 $203.87 1/15/20213,840,000 shares $820.80 million +1.1%N/A7.7 $213.75 12/31/20203,800,000 shares $833.30 million -4.5%N/A7.8 $219.29 12/15/20203,980,000 shares $934.70 million -1.7%N/A8.1 $234.85 11/30/20204,050,000 shares $941.79 million +1.3%N/A7.6 $232.54 11/15/20204,000,000 shares $916 million +7.0%N/A7.5 $229.00 10/30/20203,740,000 shares $822.69 million -13.6%N/A7.2 $219.97 10/15/20204,330,000 shares $829.54 million -3.8%N/A9.8 $191.58 9/30/20204,500,000 shares $747.23 million -5.7%N/A10.9 $166.05 9/15/20204,770,000 shares $751.99 million -0.6%N/A11.3 $157.65 8/31/20204,800,000 shares $716.98 million -1.6%N/A13 $149.37 8/14/20204,880,000 shares $677.10 million -3.4%N/A12.3 $138.75 7/31/20205,050,000 shares $612.62 million +1.8%N/A12 $121.31 7/15/20204,960,000 shares $596.64 million -0.6%N/A10.3 $120.29 6/30/20204,990,000 shares $572.35 million -2.7%N/A9.8 $114.70 6/15/20205,130,000 shares $549.78 million -0.4%N/A9.9 $107.17 5/29/20205,150,000 shares $530.45 million -14.2%N/A9.2 $103.00 5/15/20206,000,000 shares $620.22 million +5.8%N/A10.4 $103.37 4/30/20205,670,000 shares $482.18 million -2.4%N/A10.6 $85.04 4/15/20205,810,000 shares $481.59 million +0.4%N/A11.1 $82.89We’re in a code red crisis and 99% of Americans are clueless (Ad)Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! 3/31/20205,790,000 shares $494.06 million +8.9%N/A9.9 $85.33 3/13/20205,317,200 shares $433.46 million -1.2%N/A9.9 $81.52 2/28/20205,380,000 shares $393.49 million +7.8%N/A9.7 $73.14 2/14/20204,990,000 shares $432.03 million +1.2%N/A8.7 $86.58 1/31/20204,930,000 shares $437.14 million +1.4%N/A8.3 $88.67 1/15/20204,860,000 shares $460.05 million +10.5%N/A6.7 $94.66 12/31/20194,400,000 shares $400.31 million -0.2%N/A6.1 $90.98 MRTX Short Interest - Frequently Asked Questions What is Mirati Therapeutics' current short interest? Short interest is the volume of Mirati Therapeutics shares that have been sold short but have not yet been covered or closed out. As of December 31st, investors have sold 4,390,000 shares of MRTX short. Learn More on Mirati Therapeutics' current short interest. What is a good short interest ratio for Mirati Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRTX shares currently have a short interest ratio of 2.0. Learn More on Mirati Therapeutics's short interest ratio. Which institutional investors are shorting Mirati Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mirati Therapeutics: Walleye Trading LLC, and PEAK6 Investments LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Mirati Therapeutics' short interest increasing or decreasing? Mirati Therapeutics saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 4,390,000 shares, a decline of 40.7% from the previous total of 7,400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Mirati Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Mirati Therapeutics: ACADIA Pharmaceuticals Inc. (6.86%), Syndax Pharmaceuticals, Inc. (10.02%), Exelixis, Inc. (3.18%), BioMarin Pharmaceutical Inc. (3.93%), BeiGene, Ltd. (1.67%), United Therapeutics Co. (9.57%), Viatris Inc. (3.64%), Sarepta Therapeutics, Inc. (7.75%), Dr. Reddy's Laboratories Limited (1.16%), Insmed Incorporated (10.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: General Motors ($4.15 billion), T-Mobile US, Inc. ($3.92 billion), TC Energy Co. ($3.66 billion), Charter Communications, Inc. ($3.35 billion), Coinbase Global, Inc. ($3.32 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.80 billion), Rivian Automotive, Inc. ($2.44 billion), Moderna, Inc. ($2.41 billion), and United Rentals, Inc. ($2.23 billion). View all of the most shorted stocks. What does it mean to sell short Mirati Therapeutics stock? Short selling MRTX is an investing strategy that aims to generate trading profit from Mirati Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mirati Therapeutics? A short squeeze for Mirati Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRTX, which in turn drives the price of the stock up even further. How often is Mirati Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRTX, twice per month. The most recent reporting period available is December, 31 2023. More Short Interest Resources from MarketBeat Related Companies: ACADIA Pharmaceuticals Short Interest Data Syndax Pharmaceuticals Short Interest Data Exelixis Short Interest Data BioMarin Pharmaceutical Short Interest Data BeiGene Short Interest Data United Therapeutics Short Interest Data Viatris Short Interest Data Sarepta Therapeutics Short Interest Data Dr. Reddy's Laboratories Short Interest Data Insmed Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRTX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirati Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirati Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.